September 12, 2024CorporateMicroVention Rebrands to Terumo Neuro - Reflects Expanded Focus and Strategic Growth
The Latest Materials 1st Quarter Financial Results for FYE 3/2025 August 08, 2024 Financial Statements IFRS Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2025 (PDF 414.52 KB) Presentation Material Financial Results for the First Quarter of Fiscal Year Ending March 31, 2025 (PDF 550.58 KB) Financial Results for the First Quarter of Fiscal Year Ending March 31, 2025 (FY2024)(with note) (PDF 316.63 KB) Additional Information Revenue by Segment (PDF 243.41 KB) Revenue by Segment (Excel 230.75 KB) Q&A Q&A Session at the Financial Results Briefing for the First Quarter of Fiscal Year Ending March 31, 2025 (PDF 209.74 KB) Webcast Listen to the Webcast Financial Statements /investors/library/financial-statements Presentations /investors/library/presentations Terumo Report /investors/library/annual-reports Sustainability /sustainability Corporate Governance /about/governance Consolidated Financial Statements /investors/library/financial Adobe Reader is required for viewing PDF files. Download Adobe Reader
IFRS Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2025 (PDF 414.52 KB)
Financial Results for the First Quarter of Fiscal Year Ending March 31, 2025 (FY2024)(with note) (PDF 316.63 KB)
Q&A Session at the Financial Results Briefing for the First Quarter of Fiscal Year Ending March 31, 2025 (PDF 209.74 KB)